Characterization of additional vitamin D binding protein variants

Lei Fu, Chad Borges, Douglas S. Rehder, Betty Y L Wong, Rashida Williams, Thomas O. Carpenter, David E C Cole

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The gene (GC) for the vitamin D binding protein (DBP) shows significant genetic variation. Two missense variants, p.D432E and p.T436K, are common polymorphisms and both may influence vitamin D metabolism. However, less common variants, identified biochemically, have been reported previously. This study aimed to identify the underlying mutations by molecular screening and to characterize the mutant proteins by mass spectrometry. Denaturing high performance liquid chromatography (DHPLC) was used for screening genetic variants in GC exons and exon/intron boundaries of genomic DNA samples. Sanger sequencing identified the specific mutations. An immuno-capture coupled mass spectrometry method was used to characterize protein variants in serum samples. Initial molecular screening identified 10 samples (out of 761) containing an alanine deletion at codon 246 in exon 7 (p.A246del, c.737_739delCTG), and 1 sample (out of 97) containing a cysteine to phenylalanine substitution at codon 311 in exon 8 (p.C311F, c.932G. >. T). The mutant allele proteins and posttranslational modified products were distinguishable from the wild-type proteins by mass spectrum profiling. Loss of a disulfide bond due to loss of cysteine-311 was accompanied by the appearance of a novel mixed disulfide species, consistent with S-cysteinylation of the remaining unpaired cysteine-299 in the mutant protein. We confirm earlier biochemical studies indicating that there are additional deleterious GC mutations, some of which may be low-frequency variants. The major findings of this study indicate that additional mutant proteins are secreted and can be identified in the circulation. By combining molecular screening and mass spectrometric methods, mutant DBP species can be identified and characterized.

Original languageEnglish (US)
JournalJournal of Steroid Biochemistry and Molecular Biology
DOIs
StateAccepted/In press - Jun 15 2015

Fingerprint

Vitamin D-Binding Protein
Mutant Proteins
Exons
Screening
Cysteine
Codon
Disulfides
Mutation
Mass spectrometry
Mass Spectrometry
Mass Screening
Proteins
High performance liquid chromatography
Genetic Testing
Polymorphism
Phenylalanine
Metabolism
Vitamin D
Alanine
Introns

Keywords

  • Genetic variants
  • Immuno-capture coupled mass spectrometry
  • Molecular screening
  • Vitamin d binding protein

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Cell Biology
  • Molecular Biology
  • Endocrinology, Diabetes and Metabolism
  • Molecular Medicine

Cite this

Characterization of additional vitamin D binding protein variants. / Fu, Lei; Borges, Chad; Rehder, Douglas S.; Wong, Betty Y L; Williams, Rashida; Carpenter, Thomas O.; Cole, David E C.

In: Journal of Steroid Biochemistry and Molecular Biology, 15.06.2015.

Research output: Contribution to journalArticle

Fu, Lei ; Borges, Chad ; Rehder, Douglas S. ; Wong, Betty Y L ; Williams, Rashida ; Carpenter, Thomas O. ; Cole, David E C. / Characterization of additional vitamin D binding protein variants. In: Journal of Steroid Biochemistry and Molecular Biology. 2015.
@article{a61f15cc177c4a228e9967d22ff4f9b4,
title = "Characterization of additional vitamin D binding protein variants",
abstract = "The gene (GC) for the vitamin D binding protein (DBP) shows significant genetic variation. Two missense variants, p.D432E and p.T436K, are common polymorphisms and both may influence vitamin D metabolism. However, less common variants, identified biochemically, have been reported previously. This study aimed to identify the underlying mutations by molecular screening and to characterize the mutant proteins by mass spectrometry. Denaturing high performance liquid chromatography (DHPLC) was used for screening genetic variants in GC exons and exon/intron boundaries of genomic DNA samples. Sanger sequencing identified the specific mutations. An immuno-capture coupled mass spectrometry method was used to characterize protein variants in serum samples. Initial molecular screening identified 10 samples (out of 761) containing an alanine deletion at codon 246 in exon 7 (p.A246del, c.737_739delCTG), and 1 sample (out of 97) containing a cysteine to phenylalanine substitution at codon 311 in exon 8 (p.C311F, c.932G. >. T). The mutant allele proteins and posttranslational modified products were distinguishable from the wild-type proteins by mass spectrum profiling. Loss of a disulfide bond due to loss of cysteine-311 was accompanied by the appearance of a novel mixed disulfide species, consistent with S-cysteinylation of the remaining unpaired cysteine-299 in the mutant protein. We confirm earlier biochemical studies indicating that there are additional deleterious GC mutations, some of which may be low-frequency variants. The major findings of this study indicate that additional mutant proteins are secreted and can be identified in the circulation. By combining molecular screening and mass spectrometric methods, mutant DBP species can be identified and characterized.",
keywords = "Genetic variants, Immuno-capture coupled mass spectrometry, Molecular screening, Vitamin d binding protein",
author = "Lei Fu and Chad Borges and Rehder, {Douglas S.} and Wong, {Betty Y L} and Rashida Williams and Carpenter, {Thomas O.} and Cole, {David E C}",
year = "2015",
month = "6",
day = "15",
doi = "10.1016/j.jsbmb.2016.02.022",
language = "English (US)",
journal = "Journal of Steroid Biochemistry and Molecular Biology",
issn = "0960-0760",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Characterization of additional vitamin D binding protein variants

AU - Fu, Lei

AU - Borges, Chad

AU - Rehder, Douglas S.

AU - Wong, Betty Y L

AU - Williams, Rashida

AU - Carpenter, Thomas O.

AU - Cole, David E C

PY - 2015/6/15

Y1 - 2015/6/15

N2 - The gene (GC) for the vitamin D binding protein (DBP) shows significant genetic variation. Two missense variants, p.D432E and p.T436K, are common polymorphisms and both may influence vitamin D metabolism. However, less common variants, identified biochemically, have been reported previously. This study aimed to identify the underlying mutations by molecular screening and to characterize the mutant proteins by mass spectrometry. Denaturing high performance liquid chromatography (DHPLC) was used for screening genetic variants in GC exons and exon/intron boundaries of genomic DNA samples. Sanger sequencing identified the specific mutations. An immuno-capture coupled mass spectrometry method was used to characterize protein variants in serum samples. Initial molecular screening identified 10 samples (out of 761) containing an alanine deletion at codon 246 in exon 7 (p.A246del, c.737_739delCTG), and 1 sample (out of 97) containing a cysteine to phenylalanine substitution at codon 311 in exon 8 (p.C311F, c.932G. >. T). The mutant allele proteins and posttranslational modified products were distinguishable from the wild-type proteins by mass spectrum profiling. Loss of a disulfide bond due to loss of cysteine-311 was accompanied by the appearance of a novel mixed disulfide species, consistent with S-cysteinylation of the remaining unpaired cysteine-299 in the mutant protein. We confirm earlier biochemical studies indicating that there are additional deleterious GC mutations, some of which may be low-frequency variants. The major findings of this study indicate that additional mutant proteins are secreted and can be identified in the circulation. By combining molecular screening and mass spectrometric methods, mutant DBP species can be identified and characterized.

AB - The gene (GC) for the vitamin D binding protein (DBP) shows significant genetic variation. Two missense variants, p.D432E and p.T436K, are common polymorphisms and both may influence vitamin D metabolism. However, less common variants, identified biochemically, have been reported previously. This study aimed to identify the underlying mutations by molecular screening and to characterize the mutant proteins by mass spectrometry. Denaturing high performance liquid chromatography (DHPLC) was used for screening genetic variants in GC exons and exon/intron boundaries of genomic DNA samples. Sanger sequencing identified the specific mutations. An immuno-capture coupled mass spectrometry method was used to characterize protein variants in serum samples. Initial molecular screening identified 10 samples (out of 761) containing an alanine deletion at codon 246 in exon 7 (p.A246del, c.737_739delCTG), and 1 sample (out of 97) containing a cysteine to phenylalanine substitution at codon 311 in exon 8 (p.C311F, c.932G. >. T). The mutant allele proteins and posttranslational modified products were distinguishable from the wild-type proteins by mass spectrum profiling. Loss of a disulfide bond due to loss of cysteine-311 was accompanied by the appearance of a novel mixed disulfide species, consistent with S-cysteinylation of the remaining unpaired cysteine-299 in the mutant protein. We confirm earlier biochemical studies indicating that there are additional deleterious GC mutations, some of which may be low-frequency variants. The major findings of this study indicate that additional mutant proteins are secreted and can be identified in the circulation. By combining molecular screening and mass spectrometric methods, mutant DBP species can be identified and characterized.

KW - Genetic variants

KW - Immuno-capture coupled mass spectrometry

KW - Molecular screening

KW - Vitamin d binding protein

UR - http://www.scopus.com/inward/record.url?scp=84959490467&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959490467&partnerID=8YFLogxK

U2 - 10.1016/j.jsbmb.2016.02.022

DO - 10.1016/j.jsbmb.2016.02.022

M3 - Article

C2 - 26924582

AN - SCOPUS:84959490467

JO - Journal of Steroid Biochemistry and Molecular Biology

JF - Journal of Steroid Biochemistry and Molecular Biology

SN - 0960-0760

ER -